2015, Number 2
Rev Acta Médica 2015; 16 (2)
Alemañy GJ, Aragonés CB, Moreno LMM
PDF size: 155.66 Kb.
ABSTRACTIntroduction: conjunctive tumors are the most frequent of the ocular globe. They cover a wide range from benign lesions to others that may put in danger the patient’s visual function and life.
Objective: to assess the results of the treatment of mitomycin C in epithelial conjunctive-corneal neoplasia.
Method: a cross-sectional descriptive study was carried out in patients referred to the Oculoplastics consultation of "Hermanos Ameijeiras" Hospital from June 2008 and December 2012.
Results: patient at ages 50-64 years predominated (38.1%); 78.6% of the patients were white; 7.5% had a history of human papillomavirus infection; 2.5% of skin and eye cancer, and 5% of human immunodeficiency virus infection; 70% of the patients had any exposition to sunlight; in 71.4 of the le lesion was localized in the limbocorneal region; the squamous carcinoma was the most identified (42% of the patients; there was not relapses and only three complications to treatment occurred).
Conclusions: mitomycin C is useful and secure in the treatment of epithelial conjunctive-corneal neoplasia, with minimum complications.